CEVOSTAMAB

UNII:	P86BHN01VE
Formula:
Preferred Substance Name:	CEVOSTAMAB
GSRS Full Record:	P86BHN01VE i

2249888-53-5
ANTI-FCRH5/CD3 BITE ANTIBODY BFCR4350A
BFCR4350A
BFCR-4350A
BFCR4350A (ANTI-FCRH5/CD3 T-CELL DEPENDENT BISPECIFIC ANTIBODY)
CEVOSTAMAB [INN]
CEVOSTAMAB [USAN]
CEVOSTAMAB [WHO-DD]
FCRH5/CD3 T CELL DEPENDENT BISPECIFIC ANTIBODY BFCR4350A
IMMUNOGLOBULIN G1 (300-GLYCINE,369-TRYPTOPHAN), ANTI-(HUMAN FC RECEPTOR-LIKE PROTEIN FCRL5) (HUMAN-MUS MUSCULUS MONOCLONAL KFCR8534A .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL KFCR8534A .KAPPA.-CHAIN, DIMER WITH IMMUNOGLOBULIN G1 (299-GLYCINE,368-SERINE,370-ALANINE,409-VALINE), ANTI-(HUMAN CD3 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL HCDT4425A .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HCDT4425A .KAPPA.-CHAIN
RECOMBINANT ANTI-FCRH5 X ANTI-CD3 BI-SPECIFIC T-CELL ENGAGER BFCR4350A
RO7187797
RO-7187797

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CEVOSTAMAB

Synonyms and Mappings

Resources